Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

STO/GABA stock hub

STO/GABA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

STO/GABAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
24.4M
Nasdaq Stockholm
Market data

Price

Recent price action with selectable time range.

STO/GABASTO/GABA
Loading chart…
In the news

Latest news · STO/GABA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROICn/a
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All STO/GABA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
140
Groups with data
11
Currency
SEK
Showing 140 of 140 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Sweden
Country code
SE
Employees
3
Employees Change
0%
Employees Change Percent
0
Enterprise value
SEK 21.3M
Exchange
Nasdaq Stockholm
Financial currency
SEK
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
SE0010869552
Last refreshed
2026-05-10
Market cap
SEK 24.4M
Price
SEK 0.04
Price currency
SEK
Sector
Healthcare
Sic
2834
Symbol
sto/GABA
Website
https://www.gabather.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-19.05%
EV Earnings
-4.57x
P/B ratio
36.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

7
MetricValue
Net Income
SEK -4.7M
Net Income Growth Quarters
1%
Net Income Growth Years
2%
Profit Per Employee
SEK -1.6M
ROA
-78.45
Roa5y
-72.37
ROCE
-681.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr10y
-51.04%
Cagr1y
-6.55%
Cagr3y
-79.26%
Cagr5y
-62.7%
EPS Growth Quarters
7
EPS Growth Years
2
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Assets
SEK 5.4M
Cash
SEK 3.1M
Current Assets
SEK 3.8M
Current Liabilities
SEK 4.7M
Equity
SEK 662,000
Interest Coverage
-31.99
Liabilities
SEK 4.7M
Long Term Assets
SEK 1.6M
Long Term Liabilities
SEK 0
Net Cash
SEK 3.1M
Net Cash By Market Cap
SEK 12.87
Net Cash Growth
257.97%
Net Debt Equity
SEK -4.75
Tangible Book Value
SEK 662,000
Tangible Book Value Per Share
SEK 0
WACC
0.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
0.81
Net Working Capital
SEK -4.1M
Quick ratio
0.77
Working Capital
SEK -913,000

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-829.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-99.92%
1Y total return
-6.54%
200-day SMA
0.04
3Y total return
-99.11%
50-day SMA
0.04
50-day SMA vs 200-day SMA
50over200
5Y total return
-99.28%
All Time High
92.4
All Time High Change
-99.96%
All Time High Date
2015-05-12
All Time Low
0.02
All Time Low Change
73.91%
All Time Low Date
2026-01-28
ATR
0.01
Beta
-0.71
Beta1y
0.02
Beta2y
0.69
Ch YTD
45.99
High
0.04
High52
0.13
High52 Date
2025-07-22
High52ch
-69.23%
Low
0.04
Low52
0.02
Low52 Date
2026-01-28
Low52ch
73.91%
Ma50ch
-5.66%
Price vs 200-day SMA
5.54%
RSI
50.33
RSI Monthly
30.24
RSI Weekly
46.39
Sharpe ratio
0.6x
Sortino ratio
1.03
Total Return
-829.78%
Tr YTD
45.99
Tr1m
-3.38%
Tr1w
0.5%
Tr3m
33.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
SEK -4.5M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

4
MetricValue
Shares Institutions
-0.03%
Shares Out
610,491,290
Shares Qo Q
-8.79%
Shares Yo Y
829.78%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

40
MetricValue
Average Volume
6,152,461.2x
Bv Per Share
0
Ch10y
-99.92
Ch1m
-3.38
Ch1w
0.5
Ch1y
-6.54
Ch3m
33.33
Ch3y
-99.11
Ch5y
-99.28
Ch6m
29.03
Change
6.95%
Change From Open
3.09
Close
0.04
Days Gap
3.74
Dollar Volume
112,128.4
Earnings Date
2026-05-29
EBIT
SEK -4.5M
EPS
SEK -0.02
F Score
1
Financing CF
9,489,000
Fiscal Year End
December
Founded
2,014
Is Primary Listing
1
Last Earnings Date
2026-02-06
Last Report Date
2025-12-31
Last Split Date
2018-03-22
Last Split Type
Reverse
Ma150
0.03
Ma150ch
15.27%
Ma20
0.04
Ma20ch
5.54%
Net CF
2,265,000
Next Earnings Date
2026-05-29
Open
0.04
Position In Range
71.43
Price Date
2026-05-08
Ptbv Ratio
36.89
Relative Volume
0.46x
Tr6m
29.03%
Volume
2,803,209
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does STO/GABA pay a dividend?

Capital-return profile for this ticker.

Performance

STO/GABA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-6.5%
S&P 500 1Y: n/a
3Y total return
-99.1%
S&P 500 3Y: n/a
5Y total return
-99.3%
S&P 500 5Y: n/a
10Y total return
-99.9%
S&P 500 10Y: n/a
Ownership

Who owns STO/GABA?

Insider, institutional, and short-interest positioning.

Institutional ownership
-0.0%
Share of float held by funds and institutions
Insider ownership
n/a
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+829.8%
Negative means the company is buying back shares.
Technical

STO/GABA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
50.3
Neutral momentum band
Price vs 200-day MA
+5.5%
50/200-day relationship not available
Beta (5Y)
-0.71
Less volatile than the market
Sharpe ratio
0.60
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About STO/GABA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/GABA stock rating?

sto/GABA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/GABA analysis?

The full report lives at /stocks/sto/GABA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/GABA?

The latest report frames sto/GABA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/GABA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.